Results 181 to 190 of about 40,821 (327)

P16‐69: Assessment of the effect of endothelin receptor antagonist in patients with less severe or severe pulmonary hypertension associated with interstitial lung disease [PDF]

, 2021
Susumu Sakamoto, Marie Masuoka, Muneyuki Sekiya, Yusuke Usui, Hiroshige Shimizu, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Takuma Isshiki, Kazutoshi Isobe, Yujiro Takai, Atsuko Kurosaki, Sakae Homma, Kazuma Kishi, Kimitaka Akaike, Koichi Saruwatari, Ryohei Matsushima, Kosuke Fujino, Seitaro Oda, Shinya Shiraishi, Hiroko Okabayashi, Shohei Hamada, Yusuke Tomita, Aiko Masunaga, Sho Saeki, Koei Ikeda, Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami   +28 more
openalex   +1 more source

Curcumin Protected CoCl2‐Induced Apoptosis and Ferroptosis in Human Umbilical Vein Endothelial Cells by Regulating the Expression of HSPA6

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
Curcumin reduces the expression of MMP1 and MMP13 while increasing TIMP‐1 levels by downregulating HSPA6 in CoCl2‐induced HUVECs. This mechanism attenuates apoptosis, ferroptosis, and mitochondrial damage in HUVECs. These findings suggest that curcumin holds promise for the clinical treatment of hypoxia‐induced vascular diseases.
Ruihai Ye, Hang Lv, Zhe Ren, Xiaohong Yang, Xin Lv, Xue Xu   +5 more
wiley   +1 more source

Endothelin receptor antagonists for pulmonary arterial hypertension [PDF]

, 2013
Chao Liu, Junmin Chen, Yanqiu Gao, Bao Deng, Kunshen Liu   +4 more
openalex   +1 more source

Exosome‐Enhanced Injectable Hydrogels: A Comprehensive Review on Their Emerging Role in Wound Healing

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims The escalation of chronic wounds necessitates advanced therapeutic strategies beyond current interventions. Hydrogel dressings, particularly injectable hydrogels, offer promising solutions due to their water absorption capacity, structural resilience, and ease of application.
Mohammad Ebrahim Astaneh, Lalji Baldaniya, Abhayveer Singh, Ahmad Hussen, Alireza Hashemzadeh, Narges Fereydouni   +5 more
wiley   +1 more source

HJP 272, an endothelin receptor antagonist, and its role in cancer cell migration and invasion. [PDF]

Transl Oncol
Baig N, Chilamakuri R, Agarwal S, Muth A, Reznik SE.   +4 more
europepmc   +1 more source

Rate and Equilibrium Constants for the Epimerization of the Endothelin Receptor Antagonist J-104,132 in Aqueous Solution.

, 2001
Michelle Bray, Daniela GORBACHEVA, Hossain Jahansouz, Michael J. Kaufman, Kiyofumi Ishikawa, Nobuo Harada, Kimimasa Suzuki   +6 more
openalex   +2 more sources

LU135252, an endothelin_A receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction [PDF]

, 2000
Quang T. Nguyen, Federico Colombo, Jean L. Rouleau, Jocelyn Dupuis, Angelino Calderone   +4 more
openalex   +1 more source

Endothelin Receptor Antagonists [PDF]

Cardiovascular Drug Reviews, 1994
openaire   +1 more source

The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

Pediatric Pulmonology, Volume 61, Issue 1, January 2026.
ABSTRACT Background Treprostinil for the treatment of bronchopulmonary dysplasia‐associated pulmonary hypertension (BPD‐PH) has previously been described in small cohort studies, often used later in the course after failure to improve on other therapies.
Stephanie M. Tsoi, Claire Parker, Elizabeth Colglazier, Shannon Cheung, Mariam Taleb, Hythem Nawaytou, Elena Amin, Jeffrey R. Fineman, Roberta L. Keller   +8 more
wiley   +1 more source

Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i). [PDF]

JHLT Open
Kolaitis NA, Kingman M, Wilson M, Rendon GG, Lopez D, Paoli CJ, Rahman M, Martin A, McGarvey N, Lee A, Mirza S, Melendres-Groves L.   +11 more
europepmc   +1 more source